EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseOpen Access · CC BY 4.0

Effects of direct oral anticoagulants on cardiac outcomes in atrial fibrillation: a systematic review and network meta-analysis

Danilo Menichelli, Daniele Malatesta, Arianna Pannunzio, Alessio Farcomeni, Francesco Violi, Pasquale Pignatelli, Daniele Pastori

Internal and Emergency Medicine · 2026-09 · 21 (6) · 2305-2320

DOI: 10.1007/s11739-026-04480-1 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Internal and Emergency Medicine, online erschienen am 03.08.2026. Verfasst von Danilo Menichelli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Surgical Specialty and Anesthesiology, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Roma La Sapienza.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Direct oral anticoagulants (DOACs) reduce thromboembolism in atrial fibrillation (AF), but their effect on cardiac outcomes is less studied.

Methods

Systematic review and network meta-analysis were performed on AF patients on DOACs/vitamin K antagonists (VKAs). Both observational studies and randomized clinical trials (RCTs) were included. Endpoints were myocardial infarction (MI) and major adverse cardiac events (MACE). Rankograms and SUCRA were performed. Sub-group analysis included age (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsHumansAdministration, OralMyocardial InfarctionThiazolesPyrazolesRivaroxabanPyridinesFemalePyridonesThromboembolismAgedVitamin K

Stichwörter der Autor:innen

ApixabanAtrial fibrillationDabigatranDirect oral anticoagulantsEdoxabanElderlyMajor cardiovascular eventsMyocardial infarctionRivaroxabanVitamin K antagonist

Substanzen

AnticoagulantsThiazolesPyrazolesRivaroxabanPyridinesPyridonesedoxabanVitamin K

Autor:innen und Institutionen

  • Department of General Surgery, Surgical Specialty and Anesthesiology, Sapienza University of Rome, Rome, Italy.
  • Postgraduate School of Internal Medicine, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
  • Faculty of Economics, Tor Vergata University of Rome, 00133, Rome, Italy.
  • Sapienza University of Rome, Rome, Italy.
  • Department of Medical and Cardiovascular Sciences, "Sapienza" University of Rome, Viale del Policlinico 155, 00161, Rome, Italy.
  • Department of Medical and Cardiovascular Sciences, "Sapienza" University of Rome, Viale del Policlinico 155, 00161, Rome, Italy. daniele.pastori@uniroma1.it.

Förderung

  • Università degli Studi di Roma La Sapienza

Zitieren

APA

Menichelli, D., Malatesta, D., Pannunzio, A., Farcomeni, A., Violi, F., Pignatelli, P., & Pastori, D. (2026). Effects of direct oral anticoagulants on cardiac outcomes in atrial fibrillation: a systematic review and network meta-analysis. Internal and Emergency Medicine, 21(6), 2305-2320. https://doi.org/10.1007/s11739-026-04480-1

Vancouver

Menichelli D, Malatesta D, Pannunzio A, Farcomeni A, Violi F, Pignatelli P, et al. Effects of direct oral anticoagulants on cardiac outcomes in atrial fibrillation: a systematic review and network meta-analysis. Internal and Emergency Medicine. 2026;21(6):2305-2320. doi:10.1007/s11739-026-04480-1

BibTeX
@article{Menichelli2026,
  author = {Menichelli, Danilo and Malatesta, Daniele and Pannunzio, Arianna and Farcomeni, Alessio and Violi, Francesco and Pignatelli, Pasquale and Pastori, Daniele},
  title = {Effects of direct oral anticoagulants on cardiac outcomes in atrial fibrillation: a systematic review and network meta-analysis},
  journal = {Internal and Emergency Medicine},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {2305--2320},
  doi = {10.1007/s11739-026-04480-1}
}
Kostenlos starten →